NASDAQ·US·Biotechnology
MRNAMRNA
0คะแนน
สรุป
ควรหลีกเลี่ยง
ความมั่นใจ 70%
$45.72—
Today's session
Upside?
+16.2%
FV $53.14
P/E (TTM)?
—
Earnings yield
FCF yield?
-7.3%
Mcap $18.13B
ขาย
Fundamental sell·Technical neutral
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Net negative
2 · 1 · 5
Strengths
- Recent growth re-accelerating
- Modestly undervalued vs. consensus FV16%
Risks
- Capital efficiency is weak (low ROE)-14%
- Inconsistent profitability1/10
- Operating profit barely covers interest-47.1×
- Weak fundamentals signal (Piotroski ≤ 3)3/9
- ROIC below WACC — destroying value-69%
Watchlist
- Gross margins under pressure
$45.72+64.3%
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
1 of 5 models · trimmed-mean consensus
Consensus FV
$53.14
Upside
+16.2%
Now $45.72
Our FV$53.14
Price$45.72
$43.48$60.40
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Market cap
$18.13B
P/E (TTM)?
—
FCF yield?
-7.3%
Dividend
—
52w range
$22.36 – $57.80
Score confidence
70%
Data completeness
Last updated 4/30/2026, 5:22:01 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer